Cold war on brain cancer: herpes virus injected into tumors in new trial
NCT ID NCT07243340
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a modified herpes virus (C5252) injected directly into the brain tumor cavity of 36 adults with recurrent high-grade glioma who have run out of standard options. The goal is to see if the virus is safe and can help control the disease. Participants will receive one or more doses and be followed for side effects and survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA, MALIGNANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, 300060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tracer that hunts unstable iron light up hidden tumors?
- Targeted antibody may boost brain cancer treatment after incomplete surgery
- Experimental brain tumor cocktail targets recurrent glioma
- Blood tests could reveal hidden clues in aggressive brain cancer
- Brain cancer breakthrough? new trial delivers drug straight to tumor
- Surgical flap may open door to better brain tumor treatment